Rallybio Depreciation & Amortization Growth & History (RLYB)
Rallybio's depreciation and amortization was $92,000 for fiscal 2025.
View full Rallybio company overviewRallybio annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $92,000 | −$39,000 | −29.77% |
| 2024 | 2024-12-31 | $131,000 | −$19,000 | −12.67% |
| 2023 | 2023-12-31 | $150,000 | −$17,000 | −10.18% |
| 2022 | 2022-12-31 | $167,000 | $58,000 | +53.21% |
| 2021 | 2021-12-31 | $109,000 | $47,000 | +75.81% |
| 2020 | 2020-12-31 | $62,000 | — | — |
Rallybio quarterly depreciation and amortization
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $2,000 | −$24,000 | −92.31% |
| Q1 2026 | 2026-03-31 | $3,000 | −$25,000 | −89.29% |
| Q4 2025 | 2025-12-31 | $3,000 | — | — |
| Q3 2025 | 2025-09-30 | $35,000 | $3,000 | +9.38% |
| Q2 2025 | 2025-06-30 | $26,000 | −$8,000 | −23.53% |
| Q1 2025 | 2025-03-31 | $28,000 | −$7,000 | −20.00% |
| Q3 2024 | 2024-09-30 | $32,000 | −$5,000 | −13.51% |
| Q2 2024 | 2024-06-30 | $34,000 | −$4,000 | −10.53% |
| Q1 2024 | 2024-03-31 | $35,000 | −$4,000 | −10.26% |
| Q3 2023 | 2023-09-30 | $37,000 | −$5,000 | −11.90% |
| Q2 2023 | 2023-06-30 | $38,000 | −$6,000 | −13.64% |
| Q1 2023 | 2023-03-31 | $39,000 | −$3,000 | −7.14% |
| Q3 2022 | 2022-09-30 | $42,000 | $16,000 | +61.54% |
| Q2 2022 | 2022-06-30 | $44,000 | $19,000 | +76.00% |
| Q1 2022 | 2022-03-31 | $42,000 | $19,000 | +82.61% |
| Q3 2021 | 2021-09-30 | $26,000 | $11,000 | +73.33% |
| Q2 2021 | 2021-06-30 | $25,000 | — | — |
| Q1 2021 | 2021-03-31 | $23,000 | — | — |
| Q3 2020 | 2020-09-30 | $15,000 | — | — |
Rallybio depreciation and amortization trends
Over the last five fiscal years, Rallybio's depreciation and amortization increased from $62,000 to $92,000, a change of $30,000. The latest reported quarter, Q2 2026, shows $2,000.
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Rallybio source filings ↗